Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Expands By 29.3%

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 12,800 shares, an increase of 29.3% from the October 15th total of 9,900 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 2.5 days.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC lifted its holdings in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 200.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 61,342 shares of the company’s stock after purchasing an additional 40,924 shares during the period. Jane Street Group LLC owned about 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Trading Down 3.3 %

FMED stock opened at $24.67 on Friday. The stock has a market cap of $51.81 million, a PE ratio of 35.73 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 12 month low of $20.92 and a 12 month high of $26.68. The company has a 50-day moving average price of $26.00 and a 200 day moving average price of $25.04.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.